drugset / Trial / NCT06981741
Safety and Efficacy of hUC-MSC for the Treatment of Cartilage Damage in the Knee Joint
Phase 1/2
Recruiting
55 enrolled
BIONCaRT GmbH
Fraunhofer Institute for Cell Therapy and Immunology IZI · collabKKS Netzwerk · collabPolski Bank Komorek Macierzystych JSC (PBKM) · collab
NaSingle-groupOpen-labelTreatment
Summary
Testing the safety and efficacy of MSC from umbilical cord tissue (UC-MSC) for the treatment of cartilage damage in the knee joint
Timeline
- Start
- 2025-11-10
- Primary completion
- 2027-11
- Completion
- 2028-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MesemCart | Cell therapy | 1e+07 cells | Other |